These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21967660)

  • 1. Proteolytically stable cancer targeting peptides with high affinity for breast cancer cells.
    Soudy R; Gill A; Sprules T; Lavasanifar A; Kaur K
    J Med Chem; 2011 Nov; 54(21):7523-34. PubMed ID: 21967660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies of targeting ligands against breast cancer cells.
    Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
    J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
    Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
    Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
    J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.
    Horvat S; Mlinarić-Majerski K; Glavas-Obrovac L; Jakas A; Veljković J; Marczi S; Kragol G; Roscić M; Matković M; Milostić-Srb A
    J Med Chem; 2006 Jun; 49(11):3136-42. PubMed ID: 16722632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide.
    Sioud M; Mobergslien A
    Biochem Pharmacol; 2012 Nov; 84(9):1123-32. PubMed ID: 22922046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide arrays for screening cancer specific peptides.
    Ahmed S; Mathews AS; Byeon N; Lavasanifar A; Kaur K
    Anal Chem; 2010 Sep; 82(18):7533-41. PubMed ID: 20799711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
    Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
    J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer with a bi-functional peptide: in vitro and in vivo results.
    Meschenmoser K; Kim Y; Franken S; Nowak M; Feldmann G; Bendas G; Wolfgarten M; Messmer D; Schmidt-Wolf IG
    In Vivo; 2013; 27(4):431-42. PubMed ID: 23812212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel peptides through Ugi-ligation and their anti-cancer activities.
    Tahoori F; Sheikhnejad R; Balalaie S; Sadjadi M
    Amino Acids; 2013 Oct; 45(4):975-81. PubMed ID: 23864432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
    Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of a peptidic antagonist of Id1 studied by biosensor method, circular dichroism spectroscopy, and bioassay.
    Yang SY; Chen Y; Yang CX; Yang DL; Kuo SC; Huang LJ; Lung FD
    J Pept Sci; 2011 Oct; 17(10):667-74. PubMed ID: 21805537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary studies of new proteasome inhibitors in the tumor targeting approach: synthesis and in vitro cytotoxicity.
    Vivier M; Jarrousse AS; Bouchon B; Galmier MJ; Auzeloux P; Sauzieres J; Madelmont JC
    J Med Chem; 2005 Oct; 48(21):6731-40. PubMed ID: 16220988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic simplified tubulysin analogues.
    Raghavan B; Balasubramanian R; Steele JC; Sackett DL; Fecik RA
    J Med Chem; 2008 Mar; 51(6):1530-3. PubMed ID: 18314944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
    Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D
    Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.